fluorodeoxyglucose f18 has been researched along with Rhabdomyosarcoma in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.78) | 18.2507 |
2000's | 14 (38.89) | 29.6817 |
2010's | 14 (38.89) | 24.3611 |
2020's | 7 (19.44) | 2.80 |
Authors | Studies |
---|---|
Cheriyalinkal Parambil, B; Chinnaswamy, G; Kembhavi, S; Khanna, N; Laskar, S; Prasad, M; Qureshi, S; Ramadwar, M; Rangarajan, V; Sankaran, H; Shah, S; Thakur, S; Vora, T | 1 |
Gill, SM; Hassan, A; Saeed, H | 1 |
Chaika, M; Dittmann, H; Ebinger, M; Fuchs, J; Gassenmaier, S; Gatidids, S; Grimm, R; Hettmer, S; Maennlin, S; Schäfer, JF; Schmidt, A; Sparber-Sauer, M | 1 |
Fukui, T; Masuda, M; Naganuma, M; Nakamura, N; Noda, Y; Suzuki, R; Takahashi, Y; Tsuta, K; Uwamori, A | 1 |
Bahrami, A; Davidoff, AM; Green, DM; Hua, CH; Kaste, SC; Krasin, MJ; Mao, S; McCarville, MB; Merchant, TE; Ness, KK; Pappo, A; Shulkin, BL; Spunt, SL; Tinkle, CL; Wu, J | 1 |
Chi, YY; Harrison, DJ; Hawkins, DS; Hayes-Jordan, AA; Hingorani, P; Mascarenhas, L; McCowage, GB; Meyer, WH; Parisi, MT; Rodeberg, DA; Shulkin, BL; Spunt, SL; Teot, LA; Tian, J; Venkatramani, R; Weigel, BJ; Wolden, SL; Yock, TI | 1 |
Bisogno, G; Cameron, A; Chisholm, J; Coppadoro, B; Corradini, N; Gallego, S; Jehanno, N; Mercolini, F; Merks, JH; Minard-Colin, V; Rogers, T; Scarzello, G; Van Rijn, RR; Zucchetta, P | 1 |
Amiot, HM; Cassou-Mounat, T; Jehanno, N; Laurence, V; Luporsi, M | 1 |
Liang, X; Liu, Y; Ran, P; Tang, M; Xu, C; Zhu, Y | 1 |
Wu, C; Zhuang, H | 1 |
Ahmed, S; El Nadi, E; El-Kenanii, N; El-Kholy, E; Hafez, H; Khalid, E; Younes, A | 1 |
Bal, C; Kumar, R; Sharma, P; Singh, H; Suman, KC | 1 |
Armeanu-Ebinger, S; Fuchs, J; Griessinger, CM; Herrmann, D; Kneilling, M; Pichler, BJ; Seitz, G | 1 |
Biemans, R; Dubois, L; Granzier, M; Lambin, P; Lieuwes, N; Nalbantov, G; Peeters, SG; Reniers, B; Trani, D; Troost, EE; Verhaegen, F; Yaromina, A | 1 |
Baba, HA; Breithardt, G; Hermann, S; Hoffmeier, A; Köbbert, C; Möllmann, C; Schäfers, M; Scheld, HH; Sindermann, JR; Weissen-Plenz, G | 1 |
Fukuda, H; Hosono, A; Inoue, T; Kaneta, T; Kim, EE; Makimoto, A; Murakami, K; Nakamoto, Y; Suga, T; Tateishi, U; Terauchi, T | 1 |
Bui, C; Castle, VP; Frey, KA; Hutchinson, RJ; Mody, RJ; Shulkin, BL; Yanik, GA | 1 |
Daridon, A; Elizarov, AM; Heath, JR; Huang, J; Kolb, HC; Padgett, HC; Shin, YS; Shu, J; Stout, D; van Dam, RM | 1 |
Cimarelli, S; Deshayes, E; Giammarile, F; Mognetti, T; Ricard, F; Thiesse, P | 1 |
Baum, SH; Frühwald, M; Rahbar, K; Schober, O; Weckesser, M; Wessling, J | 1 |
Abraham, J; Hawkins, DS; Keller, C; Malempati, S; McHardy, SF; Michalek, JE; Nelon, LD; Prajapati, SI; Soundararajan, A; Zarzabal, LA | 1 |
Dharmarajan, KV; Fox, JJ; Gavane, S; Meyers, PA; Price, AN; Schoder, H; Tom, AK; Wexler, LH; Wolden, SL | 1 |
Bodet-Milin, C; Carlier, T; Corradini, N; Dupas, B; Eugene, T; Leux, C | 1 |
Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Mertens, J | 1 |
Alberti, W; Beck-Bornholdt, HP; Buchert, R; De Wit, M; Hossfeld, DK; Raabe, A; Seegers, B | 1 |
Bormans, G; Dubois, L; Dupont, P; Flamen, P; Haustermans, K; Landuyt, W; Mortelmans, L; Verbeken, E; Vermaelen, P | 1 |
Daridon, A; Dooley, AN; Elizarov, A; Heath, JR; Huang, J; Kolb, HC; Lee, CC; Phelps, ME; Quake, SR; Satyamurthy, N; Shin, YS; Shu, CJ; Stout, D; Sui, G; Tseng, HR; Witte, ON; Wyatt, P | 1 |
Muzik, O; Peng, F; Rabkin, G | 1 |
Buchert, R; de Wit, M; Raabe, A; Seegers, B | 1 |
Ambrosini, V; Castellucci, P; Di Leo, K; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Pession, A; Pettinato, C; Rubello, D; Spinelli, A; Tonelli, R; Trespidi, S | 1 |
Connolly, LP; Drubach, LA; Dubois, S; Frazier, L | 1 |
Grewal, RK; Klem, ML; Meyers, PA; Schöder, H; Wexler, LH; Wolden, SL | 1 |
Bell, B; Solis, V; Vinson, AE; Williams, HT | 1 |
Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Plotkin, M; Ruf, J; Schönberger, S; Steffen, I; Stöver, B; Völker, T | 1 |
Felber, S; Fink, FM; Zaknun, D; Zaknun, JJ | 1 |
Daemen, BJ; Elsinga, PH; Konings, AW; Paans, AM; Vaalburg, W; Wieringa, AR | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Rhabdomyosarcoma
Article | Year |
---|---|
Sarcomatoid renal cell carcinoma: a case report and literature review.
Topics: Carcinoma, Renal Cell; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Hematuria; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2018 |
4 trial(s) available for fluorodeoxyglucose f18 and Rhabdomyosarcoma
Article | Year |
---|---|
Efficacy and Safety of Limited-Margin Conformal Radiation Therapy for Pediatric Rhabdomyosarcoma: Long-Term Results of a Phase 2 Study.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Margins of Excision; Positron-Emission Tomography; Radiotherapy, Conformal; Rhabdomyosarcoma; Safety; Time Factors; Young Adult | 2020 |
Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rhabdomyosarcoma; ROC Curve; Treatment Outcome; Young Adult | 2012 |
PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools.
Topics: Adolescent; Adult; Child; Child, Preschool; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2007 |
31 other study(ies) available for fluorodeoxyglucose f18 and Rhabdomyosarcoma
Article | Year |
---|---|
Can 18 F-FDG-Positron Emission Tomography be a Prognostic Tool in Children With Rhabdomyosarcoma Treated With Definitive Radiotherapy?
Topics: Adolescent; Child; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma | 2023 |
18F FDG PET-CT Super scan: Paediatric Rhabdomyosarcoma.
Topics: Child; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2022 |
Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma.
Topics: Child; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tumor Burden | 2023 |
Primary Gastric Rhabdomyosarcoma.
Topics: Aged, 80 and over; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Rhabdomyosarcoma; Stomach; Tomography, X-Ray Computed | 2023 |
Metabolic response as assessed by
Topics: Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Rhabdomyosarcoma; Survival Rate | 2021 |
Role of
Topics: Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Rhabdomyosarcoma; Sarcoma | 2021 |
Rhabdomyosarcoma Revealed by a Breast Metastasis.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Rhabdomyosarcoma | 2018 |
Congenital Penile Rhabdomyosarcoma on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Infant; Male; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma | 2018 |
Added predictive value of 18F-FDG PET/CT for pediatric rhabdomyosarcoma.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Rhabdomyosarcoma; ROC Curve; Survival Analysis | 2019 |
Primary rhabdomyosarcoma of pulmonary artery: 18F-FDG PET/CT for detecting recurrence in a rare tumor.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Recurrence; Rhabdomyosarcoma; Tomography, X-Ray Computed; Vascular Neoplasms | 2013 |
PET/MR imaging and optical imaging of metastatic rhabdomyosarcoma in mice.
Topics: Animals; Dideoxynucleosides; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma | 2014 |
Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Male; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Rats; Rhabdomyosarcoma; Tumor Burden | 2015 |
Transgenic model of cardiac rhabdomyosarcoma formation.
Topics: Actins; Animals; Antigens, Viral, Tumor; Desmin; Fluorodeoxyglucose F18; Heart Neoplasms; Histocytochemistry; Mice; Mice, Transgenic; Neoplasms, Experimental; Phenotype; Positron-Emission Tomography; Rhabdomyosarcoma; Troponin C | 2008 |
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
FDG PET imaging of childhood sarcomas.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Sensitivity and Specificity; Single-Blind Method; Tomography, X-Ray Computed; Young Adult | 2010 |
Design and optimization of coin-shaped microreactor chips for PET radiopharmaceutical synthesis.
Topics: Animals; Chromatography, Ion Exchange; Elastomers; Equipment Design; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Microfluidic Analytical Techniques; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma | 2010 |
Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Lymph Nodes; Male; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Rhabdomyosarcoma; Tomography, X-Ray Computed; Young Adult | 2011 |
Contribution of PET/CT to prediction of outcome in children and young adults with rhabdomyosarcoma.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Kaplan-Meier Estimate; Male; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Mice; Podophyllotoxin; Positron-Emission Tomography; Receptor, IGF Type 1; Rhabdomyosarcoma | 2012 |
¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Rhabdomyosarcoma; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Topics: Amino Acids; Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Inflammation; Iodine Radioisotopes; Methyltyrosines; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution; Turpentine; Whole-Body Counting | 2003 |
Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
Topics: Animals; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Rats; Rhabdomyosarcoma; ROC Curve; Sarcoma, Experimental; Tomography, Emission-Computed | 2004 |
Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.
Topics: Animals; Antibodies, Monoclonal; Carbonic Anhydrase III; Cell Hypoxia; Fluorodeoxyglucose F18; Heart; Immunoenzyme Techniques; Lung; Male; Misonidazole; Muscles; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rhabdomyosarcoma | 2004 |
Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics.
Topics: Animals; Automation; Fluorides; Fluorodeoxyglucose F18; Gas Chromatography-Mass Spectrometry; Mice; Microfluidics; Miniaturization; Molecular Probes; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Solvents; Tomography, Emission-Computed | 2005 |
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
Topics: Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lung Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Skull Neoplasms | 2006 |
Potential time benefit in the assessment of recurrent rat rhabdomyosarcoma using positron emission tomography (PET) with (18)fluorodeoxyglucose depends on therapy-specific growth delay.
Topics: Animals; Feasibility Studies; Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Time Factors | 2006 |
FDG small animal PET permits early detection of malignant cells in a xenograft murine model.
Topics: Animals; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Time Factors | 2007 |
Combined effects of granulocyte colony stimulating factor and radiation.
Topics: Bone Marrow; Child; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Radiotherapy; Rhabdomyosarcoma | 2007 |
F-18-FDG-PET/CT leads to diagnosis of cryptococcal pneumonia where recurrent metastatic rhabdomyosarcoma was suspected.
Topics: Child; Cryptococcosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2007 |
Image fusion of magnetic resonance and F-18 FDG positron emission tomography using a dual-head camera in coincidence mode to determine the viability of an embryonic rhabdomyosarcoma residual mass after proton radiation and chemotherapy.
Topics: Antineoplastic Agents; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Protons; Radiopharmaceuticals; Rhabdomyosarcoma; Skull Neoplasms; Tomography, Emission-Computed | 2001 |
Radiation-induced inhibition of tumor growth as monitored by PET using L-[1-11C]tyrosine and fluorine-18-fluorodeoxyglucose.
Topics: Animals; Carbon Radioisotopes; Combined Modality Therapy; Deoxyglucose; Female; Fluorodeoxyglucose F18; Hyperthermia, Induced; Radiotherapy Dosage; Rats; Rhabdomyosarcoma; Tomography, Emission-Computed; Tyrosine | 1992 |